DHR
NYSEDANAHER CORP /DE/
Health Care, Life Sciences Tools & Services
close 7 Aug 2026
52-week change
market cap
52-week range
Expected price
Expected price
$186.81 – $228.32
Current price
$204.76
Signal
Appears fairly valued
A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.
Current multiples
Context
Forward — analyst consensus
Street view
5-year history
Dashed line: average of month-end values
P/E (TTM)
P/S (TTM)
P/B
FCF yield (TTM)
Dividend yield
period to 26 Jun 2026, filed 21 Jul 2026, close 7 Aug 2026
Discounted cash flow
Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.
Free cash flow, last ten years and TTM
5Y CAGR -0.59%10Y CAGR +4.81%
Assumptions
As filed — not assumptions
Result
Projected FCF, years 1–10
Hover for PV and growth
Projection detail
Override growth for any year; blank years use the uniform rate
| Year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth, % | 2.5 | ||||||||||
| FCF | $5.43B | $5.40B | $5.37B | $5.34B | $5.31B | $5.28B | $5.24B | $5.21B | $5.18B | $5.15B | $96.01B |
| PV | $5.03B | $4.63B | $4.26B | $3.92B | $3.61B | $3.32B | $3.06B | $2.82B | $2.59B | $2.39B | $44.47B |
period to 26 Jun 2026, filed 21 Jul 2026, close 7 Aug 2026